hygromycin b (Thermo Fisher)
99
Structured Review
Thermo Fisher
hygromycin b
Hygromycin B, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hygromycin/Hygromycin+B/pm42364981-222-16-18
Average 99 stars, based on 1 article reviews
Hygromycin B, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hygromycin/Hygromycin+B/pm42364981-222-16-18
Average 99 stars, based on 1 article reviews
hygromycin b - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Infection:Article Title: Fusion-positive rhabdomyosarcoma oncofusions share a common interactome. Article Snippet: .. After 18 hours, infected cells were pooled into a 15 cm culture dish and selected with 150 μg/ml Transduction:Article Title: Inflammatory cytokines induce new cancer dependencies. Article Snippet: Collins K. Cheruiyot, Sarah Y. Kim, Juan Dubrot , Sarah K. Lane-Reticker, Alex Miranda, Ashwin V. Kammula , Jonathan J. Perera , Peter P. Du , Cun Lan Chuong, Rachel A. Fetterman, Nelson H. Knudsen , Aiping Jiang , Juliette S. M. T. Suermondt, Lomax F. Pass, Cong Fu, Meng-Ju Wu , Lei Shi , Seth Anderson , Audrey J. Muscato , Omar I. Avila , Ian C. Kohnle, Emily A. Kessler , Hans W. Pope, Sarah G. Noel , Kira E. Olander , Jooho Chung , Kayla J. Colvin, Nabeel Bardeesy, Kathleen B. Yates & Robert T. Manguso Cell Culture:Article Title: Antibody, nucleic acid, cell, and pharmaceutical Article Snippet: An artificial gene was synthesized using, as a base, a mouse LPA1 (NP_034466, SEQ ID NO: 112) that had been registered in NCBI gene bank, and introduced into pEF5/FRT/V5-DEST (Thermo Fisher Scientific, Inc.) to construct pEF-FRT-mLPA1. pEF-FRT-mLPA1 and pOG44 plasmid (Thermo Fisher Scientific, Inc.) were simultaneously introduced into Flp-In-CHO cell (Thermo Fisher Scientific, Inc.) using Lipofectamine 2000. .. The resulting cell was cultured in a culture medium containing Article Title: Adenosine analogs for the treatment of disease Article Snippet: IB-MECA are obtained from Tocris (Bristol, UK) and N6-cyclopentyl adenosine (CPA) is obtained from Sigma-Alrich (Poole, UK). .. Cell culture media, G418 and Stable Transfection:Article Title: Antibody, nucleic acid, cell, and pharmaceutical Article Snippet: An artificial gene was synthesized using, as a base, a mouse LPA1 (NP_034466, SEQ ID NO: 112) that had been registered in NCBI gene bank, and introduced into pEF5/FRT/V5-DEST (Thermo Fisher Scientific, Inc.) to construct pEF-FRT-mLPA1. pEF-FRT-mLPA1 and pOG44 plasmid (Thermo Fisher Scientific, Inc.) were simultaneously introduced into Flp-In-CHO cell (Thermo Fisher Scientific, Inc.) using Lipofectamine 2000. .. The resulting cell was cultured in a culture medium containing Expressing:Article Title: Antibody, nucleic acid, cell, and pharmaceutical Article Snippet: An artificial gene was synthesized using, as a base, a mouse LPA1 (NP_034466, SEQ ID NO: 112) that had been registered in NCBI gene bank, and introduced into pEF5/FRT/V5-DEST (Thermo Fisher Scientific, Inc.) to construct pEF-FRT-mLPA1. pEF-FRT-mLPA1 and pOG44 plasmid (Thermo Fisher Scientific, Inc.) were simultaneously introduced into Flp-In-CHO cell (Thermo Fisher Scientific, Inc.) using Lipofectamine 2000. .. The resulting cell was cultured in a culture medium containing Binding Assay:Article Title: Antibody, nucleic acid, cell, and pharmaceutical Article Snippet: An artificial gene was synthesized using, as a base, a mouse LPA1 (NP_034466, SEQ ID NO: 112) that had been registered in NCBI gene bank, and introduced into pEF5/FRT/V5-DEST (Thermo Fisher Scientific, Inc.) to construct pEF-FRT-mLPA1. pEF-FRT-mLPA1 and pOG44 plasmid (Thermo Fisher Scientific, Inc.) were simultaneously introduced into Flp-In-CHO cell (Thermo Fisher Scientific, Inc.) using Lipofectamine 2000. .. The resulting cell was cultured in a culture medium containing Flow Cytometry:Article Title: Antibody, nucleic acid, cell, and pharmaceutical Article Snippet: An artificial gene was synthesized using, as a base, a mouse LPA1 (NP_034466, SEQ ID NO: 112) that had been registered in NCBI gene bank, and introduced into pEF5/FRT/V5-DEST (Thermo Fisher Scientific, Inc.) to construct pEF-FRT-mLPA1. pEF-FRT-mLPA1 and pOG44 plasmid (Thermo Fisher Scientific, Inc.) were simultaneously introduced into Flp-In-CHO cell (Thermo Fisher Scientific, Inc.) using Lipofectamine 2000. .. The resulting cell was cultured in a culture medium containing Negative Control:Article Title: Antibody, nucleic acid, cell, and pharmaceutical Article Snippet: An artificial gene was synthesized using, as a base, a mouse LPA1 (NP_034466, SEQ ID NO: 112) that had been registered in NCBI gene bank, and introduced into pEF5/FRT/V5-DEST (Thermo Fisher Scientific, Inc.) to construct pEF-FRT-mLPA1. pEF-FRT-mLPA1 and pOG44 plasmid (Thermo Fisher Scientific, Inc.) were simultaneously introduced into Flp-In-CHO cell (Thermo Fisher Scientific, Inc.) using Lipofectamine 2000. .. The resulting cell was cultured in a culture medium containing Fluorescence:Article Title: Antibody, nucleic acid, cell, and pharmaceutical Article Snippet: An artificial gene was synthesized using, as a base, a mouse LPA1 (NP_034466, SEQ ID NO: 112) that had been registered in NCBI gene bank, and introduced into pEF5/FRT/V5-DEST (Thermo Fisher Scientific, Inc.) to construct pEF-FRT-mLPA1. pEF-FRT-mLPA1 and pOG44 plasmid (Thermo Fisher Scientific, Inc.) were simultaneously introduced into Flp-In-CHO cell (Thermo Fisher Scientific, Inc.) using Lipofectamine 2000. .. The resulting cell was cultured in a culture medium containing FACS:Article Title: Antibody, nucleic acid, cell, and pharmaceutical Article Snippet: An artificial gene was synthesized using, as a base, a mouse LPA1 (NP_034466, SEQ ID NO: 112) that had been registered in NCBI gene bank, and introduced into pEF5/FRT/V5-DEST (Thermo Fisher Scientific, Inc.) to construct pEF-FRT-mLPA1. pEF-FRT-mLPA1 and pOG44 plasmid (Thermo Fisher Scientific, Inc.) were simultaneously introduced into Flp-In-CHO cell (Thermo Fisher Scientific, Inc.) using Lipofectamine 2000. .. The resulting cell was cultured in a culture medium containing Blocking Assay:Article Title: Antibody, nucleic acid, cell, and pharmaceutical Article Snippet: An artificial gene was synthesized using, as a base, a mouse LPA1 (NP_034466, SEQ ID NO: 112) that had been registered in NCBI gene bank, and introduced into pEF5/FRT/V5-DEST (Thermo Fisher Scientific, Inc.) to construct pEF-FRT-mLPA1. pEF-FRT-mLPA1 and pOG44 plasmid (Thermo Fisher Scientific, Inc.) were simultaneously introduced into Flp-In-CHO cell (Thermo Fisher Scientific, Inc.) using Lipofectamine 2000. .. The resulting cell was cultured in a culture medium containing Suspension:Article Title: Antibody, nucleic acid, cell, and pharmaceutical Article Snippet: An artificial gene was synthesized using, as a base, a mouse LPA1 (NP_034466, SEQ ID NO: 112) that had been registered in NCBI gene bank, and introduced into pEF5/FRT/V5-DEST (Thermo Fisher Scientific, Inc.) to construct pEF-FRT-mLPA1. pEF-FRT-mLPA1 and pOG44 plasmid (Thermo Fisher Scientific, Inc.) were simultaneously introduced into Flp-In-CHO cell (Thermo Fisher Scientific, Inc.) using Lipofectamine 2000. .. The resulting cell was cultured in a culture medium containing Selection:Article Title: A Novel Drug Candidate that Selectively Targets the Critical Androgen Receptor-ELK1 Growth Axis in Advanced and Drug-Resistant Prostate Cancer Article Snippet: The two types of recombinant cells were grown in DMEM supplemented with 5% FBS or 10% FBS, respectively, and 100 units/mL penicillin, 100 μg/mL streptomycin, 2mM L-glutamine mixture (Invitrogen). .. The selection antibiotics used in maintenance cultures of the two recombinant cell types were 100 μg/mL Recombinant:Article Title: A Novel Drug Candidate that Selectively Targets the Critical Androgen Receptor-ELK1 Growth Axis in Advanced and Drug-Resistant Prostate Cancer Article Snippet: The two types of recombinant cells were grown in DMEM supplemented with 5% FBS or 10% FBS, respectively, and 100 units/mL penicillin, 100 μg/mL streptomycin, 2mM L-glutamine mixture (Invitrogen). .. The selection antibiotics used in maintenance cultures of the two recombinant cell types were 100 μg/mL other:Article Title: Anti-CRISPR-mediated continuous directed evolution of CRISPR-Cas9 in human cells. Article Snippet: All final plasmids were verified by full plasmid sequencing (Plasmidsaurus). |